View Future GrowthBalaji Phosphates 過去の業績過去 基準チェック /46Balaji Phosphatesは、平均年間27.2%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間6.3% 26.3%収益成長率で 成長しています。 Balaji Phosphatesの自己資本利益率は13.2%であり、純利益率は7.8%です。主要情報27.23%収益成長率1.81%EPS成長率Chemicals 業界の成長17.68%収益成長率26.30%株主資本利益率13.20%ネット・マージン7.81%次回の業績アップデート29 May 2026最近の業績更新お知らせ • May 26Balaji Phosphates Limited to Report Second Half, 2026 Results on May 29, 2026Balaji Phosphates Limited announced that they will report second half, 2026 results on May 29, 2026分析記事 • Nov 22Balaji Phosphates' (NSE:BALAJIPHOS) Earnings Aren't As Good As They AppearDespite posting strong earnings, Balaji Phosphates Limited's ( NSE:BALAJIPHOS ) stock didn't move much over the last...お知らせ • Nov 14Balaji Phosphates Limited to Report First Half, 2026 Results on Nov 14, 2025Balaji Phosphates Limited announced that they will report first half, 2026 results on Nov 14, 2025Reported Earnings • Jul 09Full year 2025 earnings released: EPS: ₹4.34 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹4.34 (up from ₹3.39 in FY 2024). Revenue: ₹1.29b (down 15% from FY 2024). Net income: ₹79.2m (up 31% from FY 2024). Profit margin: 6.2% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses.Reported Earnings • Apr 03First half 2025 earnings releasedFirst half 2025 results: EPS: ₹2.43. Net income: ₹43.4m (up ₹43.4m from 1H 2024).すべての更新を表示Recent updatesお知らせ • May 26Balaji Phosphates Limited to Report Second Half, 2026 Results on May 29, 2026Balaji Phosphates Limited announced that they will report second half, 2026 results on May 29, 2026Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to ₹111, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 36% over the past year.New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.54b market cap, or US$38.4m).New Risk • Jan 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). High level of non-cash earnings (55% accrual ratio). Minor Risk Market cap is less than US$100m (₹3.06b market cap, or US$33.7m).Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹143, the stock trades at a trailing P/E ratio of 29.1x. Average trailing P/E is 23x in the Chemicals industry in India.分析記事 • Nov 22Balaji Phosphates' (NSE:BALAJIPHOS) Earnings Aren't As Good As They AppearDespite posting strong earnings, Balaji Phosphates Limited's ( NSE:BALAJIPHOS ) stock didn't move much over the last...New Risk • Nov 17New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹3.03b market cap, or US$34.2m).お知らせ • Nov 14Balaji Phosphates Limited to Report First Half, 2026 Results on Nov 14, 2025Balaji Phosphates Limited announced that they will report first half, 2026 results on Nov 14, 2025分析記事 • Oct 14Some Confidence Is Lacking In Balaji Phosphates Limited's (NSE:BALAJIPHOS) P/EWith a price-to-earnings (or "P/E") ratio of 42.2x Balaji Phosphates Limited ( NSE:BALAJIPHOS ) may be sending very...お知らせ • Sep 05Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025, at 15:00 Indian Standard Time. Location: 305 utsav avenue, 12/5 usha ganj jaora compound, mp - 452001, indore India分析記事 • Aug 22Is Balaji Phosphates (NSE:BALAJIPHOS) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹173, the stock trades at a trailing P/E ratio of 51.9x. Average trailing P/E is 27x in the Chemicals industry in India.Reported Earnings • Jul 09Full year 2025 earnings released: EPS: ₹4.34 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹4.34 (up from ₹3.39 in FY 2024). Revenue: ₹1.29b (down 15% from FY 2024). Net income: ₹79.2m (up 31% from FY 2024). Profit margin: 6.2% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses.Reported Earnings • Apr 03First half 2025 earnings releasedFirst half 2025 results: EPS: ₹2.43. Net income: ₹43.4m (up ₹43.4m from 1H 2024).Valuation Update With 7 Day Price Move • Mar 25Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹91.10, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 25x in the Chemicals industry in India.収支内訳Balaji Phosphates の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NSEI:BALAJIPHOS 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費30 Sep 251,48811696030 Jun 251,3769891031 Mar 251,2657987031 Dec 241,2226685030 Sep 241,1785283030 Jun 241,3475682031 Mar 241,5156081031 Mar 231,4686286031 Mar 221,2743375031 Mar 211,02715760質の高い収益: BALAJIPHOS 非現金収入 のレベルが高いです。利益率の向上: BALAJIPHOSの現在の純利益率 (7.8%)は、昨年(4.4%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: BALAJIPHOSの収益は過去 5 年間で年間27.2%増加しました。成長の加速: BALAJIPHOSの過去 1 年間の収益成長率 ( 122.6% ) は、5 年間の平均 ( 年間27.2%を上回っています。収益対業界: BALAJIPHOSの過去 1 年間の収益成長率 ( 122.6% ) はChemicals業界9.5%を上回りました。株主資本利益率高いROE: BALAJIPHOSの 自己資本利益率 ( 13.2% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 18:15終値2026/05/27 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Balaji Phosphates Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 26Balaji Phosphates Limited to Report Second Half, 2026 Results on May 29, 2026Balaji Phosphates Limited announced that they will report second half, 2026 results on May 29, 2026
分析記事 • Nov 22Balaji Phosphates' (NSE:BALAJIPHOS) Earnings Aren't As Good As They AppearDespite posting strong earnings, Balaji Phosphates Limited's ( NSE:BALAJIPHOS ) stock didn't move much over the last...
お知らせ • Nov 14Balaji Phosphates Limited to Report First Half, 2026 Results on Nov 14, 2025Balaji Phosphates Limited announced that they will report first half, 2026 results on Nov 14, 2025
Reported Earnings • Jul 09Full year 2025 earnings released: EPS: ₹4.34 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹4.34 (up from ₹3.39 in FY 2024). Revenue: ₹1.29b (down 15% from FY 2024). Net income: ₹79.2m (up 31% from FY 2024). Profit margin: 6.2% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses.
Reported Earnings • Apr 03First half 2025 earnings releasedFirst half 2025 results: EPS: ₹2.43. Net income: ₹43.4m (up ₹43.4m from 1H 2024).
お知らせ • May 26Balaji Phosphates Limited to Report Second Half, 2026 Results on May 29, 2026Balaji Phosphates Limited announced that they will report second half, 2026 results on May 29, 2026
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to ₹111, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 36% over the past year.
New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.54b market cap, or US$38.4m).
New Risk • Jan 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). High level of non-cash earnings (55% accrual ratio). Minor Risk Market cap is less than US$100m (₹3.06b market cap, or US$33.7m).
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹143, the stock trades at a trailing P/E ratio of 29.1x. Average trailing P/E is 23x in the Chemicals industry in India.
分析記事 • Nov 22Balaji Phosphates' (NSE:BALAJIPHOS) Earnings Aren't As Good As They AppearDespite posting strong earnings, Balaji Phosphates Limited's ( NSE:BALAJIPHOS ) stock didn't move much over the last...
New Risk • Nov 17New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹3.03b market cap, or US$34.2m).
お知らせ • Nov 14Balaji Phosphates Limited to Report First Half, 2026 Results on Nov 14, 2025Balaji Phosphates Limited announced that they will report first half, 2026 results on Nov 14, 2025
分析記事 • Oct 14Some Confidence Is Lacking In Balaji Phosphates Limited's (NSE:BALAJIPHOS) P/EWith a price-to-earnings (or "P/E") ratio of 42.2x Balaji Phosphates Limited ( NSE:BALAJIPHOS ) may be sending very...
お知らせ • Sep 05Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025, at 15:00 Indian Standard Time. Location: 305 utsav avenue, 12/5 usha ganj jaora compound, mp - 452001, indore India
分析記事 • Aug 22Is Balaji Phosphates (NSE:BALAJIPHOS) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹173, the stock trades at a trailing P/E ratio of 51.9x. Average trailing P/E is 27x in the Chemicals industry in India.
Reported Earnings • Jul 09Full year 2025 earnings released: EPS: ₹4.34 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹4.34 (up from ₹3.39 in FY 2024). Revenue: ₹1.29b (down 15% from FY 2024). Net income: ₹79.2m (up 31% from FY 2024). Profit margin: 6.2% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses.
Reported Earnings • Apr 03First half 2025 earnings releasedFirst half 2025 results: EPS: ₹2.43. Net income: ₹43.4m (up ₹43.4m from 1H 2024).
Valuation Update With 7 Day Price Move • Mar 25Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹91.10, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 25x in the Chemicals industry in India.